Catalyst Wire Dossier Catalyst Wire Dossier

Sativex

nabiximol · GW Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for Sativex, covering 2011-06-17 to 2022-12-20. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years [Phase 3]

See pricing